The Alliance for Regenerative Medicine will hold a 1.5-day workshop on Cell-based Immuno-oncology Workshop on September 4-5, 2024, in the King of Prussia, PA area. This workshop will explore the current and future state of adoptive cell therapy. The clinical landscape of autologous and allogeneic cellular immunotherapies will be explored. Hear from ARM member developers on regulatory, manufacturing, and commercialization challenges. KOL’s will highlight new developments in the field.
Key topics
• Challenges & barriers to patient access for commercial autologous CAR-T products
• Autologous CAR-T: clinical updates, patient stories, advances in manufacturing, benefits of earlier line of treatment
• Allogeneic approaches: engineering and platform strategies, analytical and genetic characterization, clinical program updates
• Novel next- gen CAR-T approaches
• Innate approaches
• IO approaches for solid tumors: 1st gen TIL and TCR success stories, recent development
• TCR therapies: CMC & regulatory considerations, screening protocol & timing, HLA diagnostics
• Regulatory topic: new guidance documents & applicability to IO
411 Swedeland Rd #100, King of Prussia, PA 19406, United States
Looking to gain extensive exposure to hundreds of top decision makers in the CGT sector? Contact Laura Stringham at lstringham@alliancerm.org to learn more about the benefits of supporting this workshop.
Please contact Josephine Lembong at jlembong@alliancerm.org
